• Print

released: 4 Oct 2016 author: AIHW

The incidence of end-stage kidney disease is an important indicator of the health of the Australian population and valuable for health-care planning. End-stage kidney disease usually requires kidney replacement therapy to survive—either dialysis or a kidney transplant—but not all people with ESKD receive these treatments for a variety of reasons. This report builds on an established method for estimating the incidence of end-stage kidney disease and indicates that for every new case treated with dialysis or transplant there is one that is not. The incidence rates of end-stage kidney disease are highest among those aged 75 and over.

ISBN 978-1-76054-008-1; Cat. no. PHE 211; 58pp.; $24

Order printed copy

Publication

Publication table of contents

  • Preliminary material
    • Title and verso pages
    • Acknowledgments
    • Abbreviations
    • Symbols
    • Summary
  • Body section
    • 1 Introduction
      • Aims of this report
      • Structure of this report
    • 2 Estimating total incidence of ESKD
      • Data sources and data linkage
      • Defining total incidence of ESKD
      • Description of the data set used in the analysis
    • 3 Total incidence of ESKD
      • Trends
      • Sex and age
      • Population groups
    • 4 Treatment status
      • Trends
      • Sex
      • Age
      • Population groups
    • 5 Causes of death
      • KRT-treated
      • Non-KRT-treated
  • End matter
    • Appendix A: Methods
    • Appendix B: Detailed statistical tables
    • References
    • List of tables
    • List of figures
    • List of boxes

Recommended citation

AIHW 2016. Incidence of end-stage kidney disease in Australia 1997–2013. Cat. no. PHE 211. Canberra: AIHW.

Request an alternative format

Please contact us if you need information from the website presented in an alternative format for accessibility reasons.